{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:27:35Z","timestamp":1762882055428,"version":"3.45.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10557-024-07577-x","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T03:01:45Z","timestamp":1718247705000},"page":"1053-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Early Rhythm or Rate Control for New Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8719-146X","authenticated-orcid":false,"given":"Jitae A.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman S.","family":"Najam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caique M. P.","family":"Ternes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qussay","family":"Marashly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihail G.","family":"Chelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"11","key":"7577_CR1","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","volume":"62","author":"RL Osnabrugge","year":"2013","unstructured":"Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.015.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"7577_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/eurheartj\/ehw456","volume":"38","author":"G Tarantini","year":"2017","unstructured":"Tarantini G, Mojoli M, Urena M, Vahanian A. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J. 2017;38(17):1285\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehw456.","journal-title":"Eur Heart J"},{"issue":"6","key":"7577_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jcin.2022.01.018","volume":"15","author":"T Ryan","year":"2022","unstructured":"Ryan T, Grindal A, Jinah R, et al. New-onset atrial fibrillation after transcatheter aortic valve replacement. JACC: Cardiovasc Interventions. 2022;15(6):603\u201313. https:\/\/doi.org\/10.1016\/j.jcin.2022.01.018.","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"14","key":"7577_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2019422.","journal-title":"N Engl J Med"},{"issue":"5","key":"7577_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for Atrial Fibrillation with Heart failure. N Engl J Med. 2018;378(5):417\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1707855.","journal-title":"N Engl J Med"},{"issue":"20","key":"7577_CR6","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","volume":"374","author":"AM Gillinov","year":"2016","unstructured":"Gillinov AM, Bagiella E, Moskowitz AJ, et al. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac surgery. N Engl J Med. 2016;374(20):1911\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1602002.","journal-title":"N Engl J Med"},{"issue":"4","key":"7577_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492\u20139. https:\/\/doi.org\/10.1093\/aje\/kwm324.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"7577_CR8","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/cir.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 update: a Report from the American Heart Association. Circulation. 2019;139(10):e56\u2013528. https:\/\/doi.org\/10.1161\/cir.0000000000000659.","journal-title":"Circulation"},{"issue":"3","key":"7577_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/jama.2012.96867","volume":"309","author":"V Prasad","year":"2013","unstructured":"Prasad V, Jena AB. Prespecified falsification end points: can they validate true Observational associations? JAMA. 2013;309(3):241\u20132. https:\/\/doi.org\/10.1001\/jama.2012.96867.","journal-title":"JAMA"},{"issue":"5","key":"7577_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jacep.2022.02.014","volume":"8","author":"D Kim","year":"2022","unstructured":"Kim D, Yang P-S, You Seng C, et al. Age and outcomes of early rhythm control in patients with Atrial Fibrillation. JACC: Clin Electrophysiol. 2022;8(5):619\u201332. https:\/\/doi.org\/10.1016\/j.jacep.2022.02.014.","journal-title":"JACC: Clin Electrophysiol"},{"issue":"11","key":"7577_CR11","doi-asserted-by":"publisher","first-page":"e024214","DOI":"10.1161\/JAHA.121.024214","volume":"11","author":"J Dickow","year":"2022","unstructured":"Dickow J, Kirchhof P, Van Houten HK, et al. Generalizability of the EAST-AFNET 4 Trial: assessing outcomes of early rhythm\u2010control therapy in patients with Atrial Fibrillation. J Am Heart Association. 2022;11(11):e024214. https:\/\/doi.org\/10.1161\/JAHA.121.024214.","journal-title":"J Am Heart Association"},{"issue":"5","key":"7577_CR12","doi-asserted-by":"publisher","first-page":"e011585","DOI":"10.1161\/circep.122.011585","volume":"16","author":"J Dickow","year":"2023","unstructured":"Dickow J, Kany S, Roth Cardoso V, et al. Outcomes of early rhythm control therapy in patients with Atrial Fibrillation and a high Comorbidity Burden in large real-world cohorts. Circ Arrhythm Electrophysiol. 2023;16(5):e011585. https:\/\/doi.org\/10.1161\/circep.122.011585.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"7577_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/circulationaha.122.060274","volume":"146","author":"A Rillig","year":"2022","unstructured":"Rillig A, Borof K, Breithardt G, et al. Early Rhythm Control in patients with Atrial Fibrillation and High Comorbidity Burden. Circulation. 2022;146(11):836\u201347. https:\/\/doi.org\/10.1161\/circulationaha.122.060274.","journal-title":"Circulation"},{"key":"7577_CR14","doi-asserted-by":"publisher","first-page":"1050744","DOI":"10.3389\/fcvm.2022.1050744","volume":"9","author":"GI Yu","year":"2022","unstructured":"Yu GI, Kim D, Sung JH, et al. Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: a nationwide cohort study. Front Cardiovasc Med. 2022;9:1050744. https:\/\/doi.org\/10.3389\/fcvm.2022.1050744.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"7577_CR15","doi-asserted-by":"publisher","first-page":"e018978","DOI":"10.1161\/jaha.120.018978","volume":"10","author":"DR Feldman","year":"2021","unstructured":"Feldman DR, Romashko MD, Koethe B, et al. Comorbidity Burden and adverse outcomes after transcatheter aortic valve replacement. J Am Heart Assoc. 2021;10(10):e018978. https:\/\/doi.org\/10.1161\/jaha.120.018978.","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"7577_CR16","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/cir.0000000000000040","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071\u2013104. https:\/\/doi.org\/10.1161\/cir.0000000000000040.","journal-title":"Circulation"},{"issue":"19","key":"7577_CR17","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.jacc.2020.03.042","volume":"75","author":"KH Chau","year":"2020","unstructured":"Chau KH, Douglas PS, Pibarot P, et al. Regression of Left Ventricular Mass after Transcatheter aortic valve replacement: the PARTNER trials and registries. J Am Coll Cardiol. 2020;75(19):2446\u201358. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.042.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"7577_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","volume":"384","author":"JG Andrade","year":"2020","unstructured":"Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or Drug Therapy for initial treatment of Atrial Fibrillation. N Engl J Med. 2020;384(4):305\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2029980.","journal-title":"N Engl J Med"},{"issue":"7","key":"7577_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/circulationaha.122.058575","volume":"146","author":"DS Chew","year":"2022","unstructured":"Chew DS, Li Y, Cowper PA, et al. Cost-effectiveness of catheter ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: the CABANA Randomized Clinical Trial. Circulation. 2022;146(7):535\u201347. https:\/\/doi.org\/10.1161\/circulationaha.122.058575.","journal-title":"Circulation"},{"issue":"7","key":"7577_CR20","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/jhm.445","volume":"4","author":"PP Kneeland","year":"2009","unstructured":"Kneeland PP, Fang MC. Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med. 2009;4(7):E1\u20135. https:\/\/doi.org\/10.1002\/jhm.445.","journal-title":"J Hosp Med"},{"issue":"1","key":"7577_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.hrthm.2014.09.049","volume":"12","author":"K Nademanee","year":"2015","unstructured":"Nademanee K, Amnueypol M, Lee F, et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm. 2015;12(1):44\u201351. https:\/\/doi.org\/10.1016\/j.hrthm.2014.09.049.","journal-title":"Heart Rhythm"},{"issue":"11","key":"7577_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.121.055297","volume":"145","author":"TD Bahnson","year":"2022","unstructured":"Bahnson TD, Giczewska A, Mark DB, et al. Association between Age and outcomes of catheter ablation Versus Medical Therapy for Atrial Fibrillation: results from the CABANA Trial. Circulation. 2022;145(11):796\u2013804. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055297.","journal-title":"Circulation"},{"issue":"17","key":"7577_CR23","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","volume":"11","author":"N Vora Amit","year":"2018","unstructured":"Vora Amit N, Dai D, Matsuoka R, et al. Incidence, management, and Associated Clinical outcomes of New-Onset Atrial Fibrillation following transcatheter aortic valve replacement. JACC: Cardiovasc Interventions. 2018;11(17):1746\u201356. https:\/\/doi.org\/10.1016\/j.jcin.2018.05.042.","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"6","key":"7577_CR24","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/strokeaha.121.036757","volume":"53","author":"D Kim","year":"2022","unstructured":"Kim D, Yang PS, Sung JH, et al. Effectiveness and safety of Anticoagulation Therapy in Frail patients with Atrial Fibrillation. Stroke. 2022;53(6):1873\u201382. https:\/\/doi.org\/10.1161\/strokeaha.121.036757.","journal-title":"Stroke"},{"issue":"9921","key":"7577_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/s0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(13)62343-0.","journal-title":"Lancet"},{"issue":"15","key":"7577_CR26","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jcin.2021.05.025","volume":"14","author":"R Didier","year":"2021","unstructured":"Didier R, Lhermusier T, Auffret V, et al. TAVR patients requiring anticoagulation. JACC: Cardiovasc Interventions. 2021;14(15):1704\u201313. https:\/\/doi.org\/10.1016\/j.jcin.2021.05.025.","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"23","key":"7577_CR27","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","volume":"385","author":"NM Van Mieghem","year":"2021","unstructured":"Van Mieghem NM, Unverdorben M, Hengstenberg C, et al. Edoxaban versus vitamin K antagonist for Atrial Fibrillation after TAVR. N Engl J Med. 2021;385(23):2150\u201360. https:\/\/doi.org\/10.1056\/NEJMoa2111016.","journal-title":"N Engl J Med"},{"key":"7577_CR28","doi-asserted-by":"publisher","first-page":"101239","DOI":"10.1016\/j.ijcha.2023.101239","volume":"47","author":"JK Petersen","year":"2023","unstructured":"Petersen JK, Fosb\u00f8l EL, Strange JE, et al. Impact of first-time detected atrial fibrillation after transcatheter aortic valve replacement: a nationwide study. IJC Heart Vasculature. 2023;47:101239. https:\/\/doi.org\/10.1016\/j.ijcha.2023.101239.","journal-title":"IJC Heart Vasculature"},{"key":"7577_CR29","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.ijcha.2021.100910","volume":"38","author":"N Nso","year":"2022","unstructured":"Nso N, Emmanuel K, Nassar M, et al. Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement\/implantation. IJC Heart Vasculature. 2022;38:100910. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100910.","journal-title":"IJC Heart Vasculature"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07577-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:21:49Z","timestamp":1762881709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07577-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7577"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07577-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"8 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required given the use of de-identified data only.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}